Allspring Global Investments’s Kura Oncology KURA Stock Holding History

Allspring Global Investments’s Portfolio KURA Stock Details KURA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$194K	Buy	23,297 +2,304	+11%	+$19.8K	﹤0.01%	1613
2025 Q4	$217K	Buy	20,993 +1,825	+10%	+$19.1K	﹤0.01%	1566
2025 Q3	$176K	Buy	+19,168	New	+$137K	﹤0.01%	1560
2023 Q4	–	Sell	-350	Closed	-$3.19K	–	2495
2023 Q3	$3.19K	Sell	350 -1,270	-78%	-$12.9K	﹤0.01%	2693
2023 Q2	$17.1K	Sell	1,620 -2,469	-60%	-$29.2K	﹤0.01%	2483
2023 Q1	$50K	Buy	4,089 +3,248	+386%	+$40.5K	﹤0.01%	2289
2022 Q4	$10.4K	Sell	841 -19	-2%	-$276	﹤0.01%	2704
2022 Q3	$11K	Buy	+860	New	+$13.3K	﹤0.01%	2718

Other funds holding KURA

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return

Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Allspring Global Investments's KURA Position: Q1 2026 in Review

Allspring Global Investments increased its Kura Oncology (KURA) stake by 11% in Q1 2026, buying an estimated $19.8K and bringing the position to 23,297 shares worth $194K. The position accounts for ﹤0.01% of the portfolio, ranked #1613.

Allspring Global Investments first reported a position in KURA in Q3 2022 and has held it in 8 quarters since. The position peaked at $217K in Q4 2025. 222 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

Allspring Global Investments held 23,297 shares of Kura Oncology worth $194K as of Q1 2026.
Allspring Global Investments bought 2,304 Kura Oncology shares in Q1 2026, an estimated $19.8K.
Kura Oncology made up ﹤0.01% of Allspring Global Investments's portfolio in Q1 2026, its #1613 holding.
Allspring Global Investments first reported a position in Kura Oncology in Q3 2022 and has held it in 8 quarters since.
Allspring Global Investments's Kura Oncology position peaked at $217K in Q4 2025.
222 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on Allspring Global Investments's 13F filing for Q1 2026, filed 5 May 2026.